Press Releases

    • November 8, 2018

    Nemaura Medical Inc. Reports Second Quarter 2018 Financial Results

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible...

    Read more
    November 7, 2018

    Nemaura Successfully Develops Predictive Algorithms and Alarm Functionality for Continuous Glucose Monitor SugarBEAT®

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible...

    Read more
    October 22, 2018

    Nemaura to Host Investor Webinar on October 23rd 2018 to Provide Update on Recent Developments

    LOUGHBOROUGH, England – Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible...

    Read more
    September 25, 2018

    Nemaura Reports Positive Zero Finger-Stick Calibration Data for SugarBEAT® Continuous Glucose Monitor

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible...

    Read more
    September 18, 2018

    Nemaura Signs Letter of Intent for SugarBEAT® Commercial Launch in Qatar

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous...

    Read more
    September 12, 2018

    Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT® FDA Clinical Trial

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible...

    Read more
    August 28, 2018

    Nemaura Medical Strengthens Manufacturing Team in Preparation for SugarBEAT® Commercial Launch.

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device...

    Read more
    August 9, 2018

    Nemaura Medical Inc. Reports First Quarter 2018 Financial Results

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device...

    Read more
    July 31, 2018

    Nemaura Initiates US FDA Studies, and Reports Positive Interim Data from Home-Use Portion of Study

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device...

    Read more
    July 17, 2018

    Nemaura Places SugarBEAT® Manufacturer Order for UK Commercial Launch

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    Read more